Raleigh, NC, United States of America

Govindarajan Manikumar



Average Co-Inventor Count = 4.2

ph-index = 10

Forward Citations = 344(Granted Patents)


Company Filing History:


Years Active: 1990-2006

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Innovations of Govindarajan Manikumar

Introduction

Govindarajan Manikumar is a prominent inventor based in Raleigh, NC (US). He has made significant contributions to the field of anti-tumor compounds, holding a total of 16 patents. His work focuses on developing effective treatments for cancer through innovative chemical compounds.

Latest Patents

One of his latest patents is for Camptothecin analogs having an E-ring ketone. These compounds are recognized as effective anti-tumor agents, as they inhibit the enzyme topoisomerase I and may alkylate DNA within the associated topoisomerase I DNA cleavable complex. Another notable patent involves 7-substituted camptothecin and methods for producing these compounds. This patent also emphasizes the effectiveness of these camptothecin compounds as anti-tumor agents, highlighting their ability to inhibit topoisomerase I and interact with DNA.

Career Highlights

Throughout his career, Govindarajan has worked with various organizations, including the Research Triangle Institute. His innovative research has led to advancements in cancer treatment, showcasing his dedication to improving healthcare through scientific discovery.

Collaborations

Govindarajan has collaborated with notable figures in the field, including Mansukh C. Wani and Monroe E. Wall. These partnerships have contributed to the development of groundbreaking anti-tumor compounds.

Conclusion

Govindarajan Manikumar's contributions to the field of anti-tumor research through his patents and collaborations highlight his role as a significant inventor. His work continues to impact cancer treatment and showcases the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…